Medication info
Zocona Tablet 20 mg (Simvastatin)

Zocona Tablet 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
NexPharm Korea Co., Ltd.
Appearance
Brown oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201707670 · Approved 2017.10.31 · Insurance code 662503750

Summary

Main use
Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL-cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be administered under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dosage adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor closely.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose individually according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
NexPharm Korea Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication effectively reduces the risk of death from coronary heart disease, myocardial infarction, and stroke in adult patients at high risk for cardiovascular disease. It also helps reduce the risk of complications that may occur after arterial revascularization. It is used to treat hyperlipidemia, particularly lowering total cholesterol and LDL cholesterol levels while increasing HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. This drug is also suitable for patients with homozygous and heterozygous familial hypercholesterolemia and can improve blood lipid levels in pediatric patients under specific criteria. Overall, this drug is used to promote cardiovascular health and control blood lipid concentrations.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL-cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be administered under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dosage adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor closely.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose individually according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis, especially when taken in high doses. Therefore, patients taking high doses are recommended to use other medications with fewer drug interactions or a lower dose. Patients with allergies to this medication, those with liver disease, women who are pregnant or breastfeeding, or those taking specific powerful medications should not take this medication. Alcoholics or patients with poor liver or kidney function, those with hypothyroidism or history of muscle disease should use this medication with great caution. If symptoms such as muscle pain, muscle weakness, or unexplained muscle symptoms occur while taking this medication, inform your doctor immediately and discontinue the medication if necessary. Liver function abnormalities may occur, so regular liver function tests should be conducted, and treatment should be stopped if any abnormalities are noted. This medication can interact with various drugs; therefore, anyone taking other medications should inform their doctor or pharmacist. In particular, the risk of myopathy may be increased when used in conjunction with certain antifungals, antibiotics, immunosuppressants, and calcium channel blockers. Women who are pregnant or may become pregnant should not take this medication and should discontinue it immediately if pregnancy is confirmed. Breastfeeding women should also stop breastfeeding if taking this medication. This medication is not used in children under 10 years old or premenarchal girls. Elderly patients, especially those aged 65 and older, should take extra caution as they are at a higher risk for myopathy while using this medication. It is advisable to avoid grapefruit juice while taking this medication, and if an overdose occurs, seek medical help immediately. This medication should be kept out of reach of children and stored in its original container for safety.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 86 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • drug rash resembling lichen planus
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like erythema syndrome
  • rheumatoid polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • pancreatitis
  • acute liver failure
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • limb paresthesia
  • numbness
  • cold sensation
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air entry, at room temperature between 1°C to 30°C. Storing it this way will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Brown oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.